Dr Annet Nakaganda

Dr. Annet Nakaganda, is a Clinical Officer and a Cancer Epidemiologist specialized in the conduct of clinical trials and epidemiological investigations for cancer control in Uganda. She holds a PhD in medicine and a Master’s degree in Public Health (Distinction) from the University of Manchester UK. Annet is trained and experienced in Teaching at University levels. She started her teaching career in 2016 as a Teaching Associate at The University of Manchester Masters of Public Health Program (MPH) and the Biochemistry of Disease unit. Dr. Nakaganda has been involved in clinical research for over 20 years now, serving in various positions including: principal investigator, research clinician; research coordination; research governance and research monitoring/auditing. She currently Heads the Cancer Epidemiology and Clinical Trials Unit at the Uganda cancer Institute (UCI) and is a supervisor for Field Epidemiology Fellows. Dr. Nakaganda’s career in clinical research started way back in early 2000s, with clinical trials aimed at Prevention of Mother to Child Transmission (PMTCT) of HIV. This research included the landmark HIV Network for Prevention Trials (HIVNET) study number 012, which led to the widespread use of single-dose Nevirapine, an effective, low-cost intervention for PMTCT then. She later moved on to cancer research and has worked to establish the Cancer Epidemiology and Clinical Trials Unit at the Uganda Cancer Institute and she led the harmonization of cancer registration guidelines for East Africa. She also serves as instructor for Research Ethics and Good Clinical Practice and has conducted approximately 50 in-country trainings and trained over 600 researchers in Research Ethics. Annet is a winner of several awards and has published in peer reviewed international journals and conferences. Her recent/current work is focused on expanding best practices for cancer research and control, and identifying novel approaches for accelerating timely availability/utilization of locally-generated evidence to direct the cancer control effort in low-resource settings.